Biologics Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2023 Earnings Call Transcript February 14, 2024 Charles River Laboratories International, Inc. beats earnings expectations. Reported EPS is $2.46, expectations were $2.39. Charles River Laboratories International, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details […]

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories First Quarter 2023 Earnings Conference Call. This call is being recorded.

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Fourth Quarter and Full Year 2022 Earnings Conference Call. This call is being recorded.

HCP-ELISA builds upon Company’s HCP-GAPex℠ service, increasing the efficiency and efficacy of HCP assay developmentWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for...

Charles River Laboratories International, Inc. (NYSE:NYSE:CRL) Q3 2022 Earnings Conference Call November 2, 2022 09:00 AM ET Company Participants Todd Spencer - VP, IR James Foster -...